Johnson & Johnson
- News
Johnson & Johnson’s standalone nasal spray for depression gets FDA nod
The United States Food and Drug Administration (FDA) has approved Spravato, a nasal spray by Johnson & Johnson as a stand-alone treatment for adults with Major Depressive Disorder (MDD). The spray is…
- World
Johnson & Johnson willing to pay $9bn to settle talc claims: Report
London: US pharmaceutical giant Johnson & Johnson has proposed to pay almost $9 billion to resolve tens of thousands of lawsuits the company faces in North America over claims that its baby…
- Mumbai
Bombay HC orders fresh testing of Johnson & Johnson baby powder; allows manufacture but not sale
Mumbai: The Bombay High Court on Wednesday ordered for fresh testing of Johnson & Johnson baby powder samples and permitted the company to manufacture the product but to not sell it, as…
- India
Maha: FDA cancels Johnson & Johnson’s licence to make baby powder
Mumbai: The Maharashtra FDA has cancelled the baby talcum powder manufacturing licence of Johnson & Johnson (J&J), from its sole plant in the state at Mulund, officials said. The FDA said that…
- Middle East
J&J talc powder sold in Saudi Arabia is safe: SFDA
Riyadh: The Kingdom of Saudi Arabia’s Food and Drug Authority (SFDA) on Monday confirmed that Johnson & Johnson (J&J) baby talcum powder sold in the Kingdom does not contain harmful asbestos. The…
- World
Johnson & Johnson to stop selling, making talc-based baby powder
London: Johnson & Johnson is to stop selling and making talc-based baby powder globally, two years after it ended sales in the US and Canada, the media reported. The healthcare firm has…
